Press Release 2009

Sabinsa, the international ingredients company, has received notification that two additional patents have been granted.

The company’s Garcitrin® product is now protected by Japanese patent number 4205943 for "Bioavailable composition of natural and synthetic HCA." The hydroxycitric acid (HCA) has been uniquely combined with garcinol, a polyisoprenylated benzophenone isolated from Garcinia cambogia and Garcinia indica fruits, the result is GarCitrin®. In GarCitrin®, garcinol enhances the biological action of HCA and also contributes antioxidant activity to the formulation. A 12-week, double blind clinical with over 40 patients statistically proved GarCitrin® is statistically more effective than HCA alone in:

  • Reducing total body weight and body mass index
  • Reducing body fat
  • Increasing lean body mass
  • Reducing levels of appetite perception

Garcitrin® is also protected by other international patents, U.S.A. 7,063,861; AU773081; EP1254209; NZ518116.

The Australian government granted Sabinsa’s cosmetic Curcumin ingredient - Tetrahydrocurcuminoids, patent number AU 2006235807, for the “Use of Tetrahydrocurcuminoids to regulate physiological and pathological events in the skin and mucosa.” This off-white Curcumin powder is ideal for cosmetic applications looking for superior antioxidant effectiveness.

The composition of tetrahydrocurcuminoids helps to:

  • Support healthy aging of tissues through regulating random intracellular protein crosslinking
  • Optimizing cell electric potential
  • Increasing intracellular transglutaminase activity
  • Reducing "age spots" due to lipofuscin formation 



  • Sabinsa Corporation
    20 Lake Drive
    East Windsor
    NJ 08520, USA

  • +1 732 777 1111
  • +1 732 777 1443


Certificate Logos Certificate Logos
Certificate Logos Certificate Logos